Research and Development

A unit of US health maintenance organisation Kaiser Permanente has become the fourth in Quintiles’ network of ‘Prime Sites’ – …

A phase III trial of Novartis’ ranibizumab has shown it to be superior at promoting vision gain in patients with …

Boehringer Ingelheim has selected a lead candidate for further development to treat Alzheimer’s disease from its collaboration with Ablynx. Belgium-based …

Japanese drugmaker Eisai has opened a 65,000-sq.ft. facility at Research Triangle Park in North Carolina, USA, which will serve as …

Scientists in the US have succeeded in developing the first living cell to be controlled entirely by synthetic DNA. The …

Jorg Kaufmann has been made vice president of research at UK biotech company Silence Therapeutics. He previously served as senior …

UK biotech Antisoma is looking to put previous late-stage trial failures behind it by focusing on two new cancer drugs. …

 ReNeuron’s chief scientific officer discusses his career to date. How did you find your way into your current role?

This builds further upon Chiltern’s well established operation in India. Chiltern is also in the process of forming a company …

UCB’s chief executive Roch Doliveux has joined the governing board of the Innovative Medicines Initiative. The IMI is a public-private …

Ferring UK has appointed Steve Howson as its new general manager. He will have responsibility for operations in the UK …

European regulators are readying themselves to deal with the region’s first marketing authorisation application for a stem cell product. The …

Pfizer is teaming up with academia in a five-year bid to discover new uses for existing compounds. The pharma manufacturer …

Bayer Schering Pharma has expanded its global research network, opening a new Innovation Center in San Francisco. The US centre …

Merck & Co’s heart disorder drug Brinavess has proved superior to rival amiodarone in reducing rates of atrial fibrillation in …